- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 498/08 - Bridged systems
Patent holdings for IPC class C07D 498/08
Total number of patents in this class: 1087
10-year publication summary
|
71
|
59
|
67
|
82
|
61
|
60
|
73
|
78
|
96
|
68
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2705 |
37 |
| Bristol-myers Squibb Company | 4867 |
32 |
| VALO Health, Inc. | 174 |
32 |
| Amgen Inc. | 4106 |
22 |
| Bayer Pharma AG | 1054 |
19 |
| Janssen Pharmaceutica N.V. | 3369 |
18 |
| Bayer AG | 3343 |
18 |
| Merck Sharp & Dohme LLC | 3760 |
18 |
| Novartis AG | 10730 |
17 |
| F. Hoffmann-La Roche AG | 7941 |
17 |
| Boehringer Ingelheim International GmbH | 4642 |
17 |
| Vertex Pharmaceuticals Incorporated | 1623 |
17 |
| Pfizer Inc. | 3368 |
12 |
| Epizyme, Inc. | 374 |
12 |
| Merck Patent GmbH | 5824 |
11 |
| Enanta Pharmaceuticals, Inc. | 429 |
11 |
| Voronoi Inc. | 59 |
11 |
| Purdue Pharma L.P. | 500 |
10 |
| Taisho Pharmaceutical Co., Ltd. | 866 |
10 |
| Theravance Biopharma R&D IP, LLC | 456 |
10 |
| Other owners | 736 |